Low sADC Predicts Poor Outcomes in Cervical Cancer with PD-1 Inhibitors
Can imaging predict how well cervical cancer patients respond to treatment?
In a study of 167 cervical cancer patients, lower substantial ADC (sADC) correlated with worse PFS (HR=1.81, P=0.005) and OS (HR=2.40, P=0.0…
Low water movement in cervical cancer tumors on scans predicts worse survival when patients take immunotherapy, helping doctors choose bette…
Meta-analysis: Zinc supplements show time-dependent efficacy in preventing oral mucositis after chemoradiotherapy
Can a simple mineral help cancer patients avoid painful mouth sores from treatment? New analysis says yes, with timing being key
A meta-analysis of 16 RCTs (n≈1076) found zinc supplementation significantly delayed OM onset (MD=1.37, 95% CI: 0.78 to 1.95, P<0.001) and r…
Zinc supplements delay painful mouth sores in cancer patients and reduce risk at 2 weeks and 7-9 weeks, with timing and dosage being key to …
Higher TFF1 Expression Linked to Lower Bilateral Retinoblastoma Risk
Could a simple test help identify retinoblastoma risk in children?
In a meta-analysis of 521 retinoblastoma patients, higher TFF1 expression was linked to reduced bilateral involvement (RR=0.57, p=0.0041) an…
A new test for a protein called TFF1 could help doctors spot retinoblastoma risk in children and predict if the cancer will affect both eyes…
Guided Breathing VR Reduces Opioid Use Post-PTBD in Cancer Patients by 64%
Can Virtual Reality and Breathing Techniques Reduce Cancer Pain?
In a randomized trial, guided breathing VR (VRBG) significantly reduced opioid use post-PTBD compared to conventional VR (VROG), with a mean…
Cancer patients using virtual reality with guided breathing took significantly less pain medication after a painful procedure than those usi…
Atezolizumab with mFOLFOX6 Boosts 3-Year DFS by 10.1% in Stage III dMMR Colon Cancer
Could a New Treatment Boost Survival for Stage III Colon Cancer Patients?
In a phase 3 trial, atezolizumab plus mFOLFOX6 improved 3-year disease-free survival to 86.3% vs. 76.2% with mFOLFOX6 alone (HR 0.50; 95% CI…
Adding atezolizumab to standard chemotherapy boosted 3-year disease-free survival to 86% in stage III colon cancer patients, up from 76% wit…
CSF ctDNA Status Predicts Survival in Leptomeningeal Metastases: Meta-Analysis
Can a Simple Test in Spinal Fluid Predict Survival for Cancer Patients?
In a meta-analysis of 14 studies (n=963), adverse baseline CSF ctDNA status was linked to worse OS (HR 2.40, 95% CI 1.73-3.33) and PFS (HR 2…
A simple spinal fluid test can predict how long someone with advanced cancer might live by spotting DNA markers linked to shorter survival t…